parecoxib has been researched along with Injury, Myocardial Reperfusion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J; Li, S; Wang, P; Wang, X; Zhao, G; Zhao, H | 1 |
| Duan, Y; Guo, J; Li, G; Ma, T; Wang, W; Wu, F | 1 |
| Abbate, A; Hoke, NN; Houser, JE; Ownby, ED; Salloum, FN; Seropian, IM; Van Tassell, BW; Varma, A | 1 |
3 other study(ies) available for parecoxib and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Parecoxib protects against myocardial ischemia/reperfusion via targeting PKA-CREB signaling pathway.
Topics: Apoptosis; Humans; Isoxazoles; Myocardial Reperfusion Injury; Signal Transduction | 2022 |
Effect of Parecoxib Sodium on Myocardial Ischemia-Reperfusion Injury Rats.
Topics: Animals; Apoptosis; Cardiotonic Agents; Cytokines; Heart Function Tests; Inflammation Mediators; Isoxazoles; Myocardial Reperfusion Injury; Myocardium; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Parecoxib inhibits apoptosis in acute myocardial infarction due to permanent coronary ligation but not due to ischemia-reperfusion.
Topics: Acute Disease; Animals; Apoptosis; Coronary Stenosis; Coronary Vessels; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Echocardiography; Injections, Intraperitoneal; Isoxazoles; Ligation; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Ventricular Remodeling | 2009 |